FMP
PNK
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
0.0065 USD
-0.0015 (-23.08%)
Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
Healthcare
Biotechnology
https://novaccessglobal.com
PNK
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
0001039466
US67001N1072
67001N107
8834 Mayfield Road
440 644 1027
US
3
Sep 21, 1998